Today: 21 March 2026
DBS stock price ends week near a 52-week high as Fed decision and Feb 9 earnings loom
25 January 2026
1 min read

DBS stock price ends week near a 52-week high as Fed decision and Feb 9 earnings loom

SINGAPORE, Jan 25, 2026, 14:48 SGT — Market closed

  • DBS shares closed up 1% at S$58.65, lingering just 1% below their 52-week high
  • After the Bank of Japan held steady, global rate signals drew fresh scrutiny ahead of the Fed’s January 27-28 meeting
  • DBS will report its fourth-quarter results on Feb 9, with investors closely watching margins and dividends.

DBS Group Holdings Ltd shares ended Friday at S$58.65, gaining 0.98% after moving between S$57.90 and S$58.83 earlier in the day. The stock is still about 1% below its 52-week high of S$59.25. Yahoo Finance

This change matters because rate forecasts could shift once more this week, affecting bank valuations directly. DBS will report its quarterly results in two weeks, where it must outline its perspective on what “normal” earnings mean as borrowing costs ease.

Asian risk appetite improved Friday after the Bank of Japan kept rates unchanged but revised its growth and inflation forecasts upward, hinting at possible gradual tightening ahead. “The tone appears hawkish,” said David Chao, global market strategist for Asia-Pacific at Invesco in Singapore. Reuters

For DBS, the spotlight remains firmly on net interest margin — the difference between what it earns on loans and pays on deposits. In the latest quarter, both DBS and Singapore peer UOB reported margin squeeze as interest rates softened, a headache investors have yet to shake off. Reuters

All eyes are on the U.S. Federal Reserve’s Jan. 27-28 meeting, with the policy decision and press conference set for Jan. 28. Any shift in the Fed’s language could ripple through global rate markets and alter banks’ lending spreads. Federal Reserve

DBS will unveil its fourth-quarter 2025 results on Feb. 9. Investors are focused on margin pressure, credit costs, and the bank’s strategy for capital returns—particularly the dividend it intends to uphold throughout the current cycle. DBS Bank

The setup still holds risks. Should interest rates fall more quickly than anticipated, margins could tighten. Plus, a slowdown in regional growth might push bad-loan charges higher, eating into earnings that appear stable—right up until they don’t.

The stock’s next key moment arrives Monday in the Singapore session, with traders watching global rates and Asia FX closely after the BOJ’s announcement. The bigger milestone, though, is Feb. 9, when DBS rolls out its report and new data lands for investors to weigh.

Stock Market Today

  • Abbott Laboratories (ABT) Shares Dip Amid Valuation Debate: Is This a Buying Opportunity?
    March 21, 2026, 1:04 AM EDT. Abbott Laboratories' (ABT) share price has declined 15% year-to-date, trading around US$105, sparking debate on whether it's a value trap or a long-term opportunity. Analysis using discounted cash flow (DCF) models estimates the stock's intrinsic value at approximately $164.42 per share, signalling a potential 35.9% undervaluation. The healthcare giant's recent performance lags peers amid investor caution over medical equipment demand and capital allocation strategies. Analyst forecasts project free cash flow reaching $11.46 billion by 2028, supporting bullish valuation metrics despite recent stock weakness. Investors are advised to consider these fundamentals alongside sector risks when assessing ABT shares.
Macquarie share price: MQG heads into Australia Day pause with CPI and rate bets in focus
Previous Story

Macquarie share price: MQG heads into Australia Day pause with CPI and rate bets in focus

South32 share price near a 52-week high: what to watch as Australia Day shuts ASX
Next Story

South32 share price near a 52-week high: what to watch as Australia Day shuts ASX

Go toTop